XRCC5 MUTANT MICE AND CELL LINES

Information

  • Research Project
  • 2451164
  • ApplicationId
    2451164
  • Core Project Number
    R01CA076317
  • Full Project Number
    1R01CA076317-01
  • Serial Number
    76317
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/7/1997 - 27 years ago
  • Project End Date
    5/31/2000 - 24 years ago
  • Program Officer Name
  • Budget Start Date
    7/7/1997 - 27 years ago
  • Budget End Date
    5/31/1998 - 26 years ago
  • Fiscal Year
    1997
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/7/1997 - 27 years ago

XRCC5 MUTANT MICE AND CELL LINES

The goal of this project is to investigate the function of Ku80 in tissue culture cells and in mice so that we may better understand those pathways that repair DNA double-strand breaks (DSBs) and monitor DNA damage. A Ku80 - Ku70 heterodimer forms the DNA binding component of DNA-dependent protein kinase (DNA-PK) and a third protein, DNA-PKcs, is the catalytic subunit. A deficiency in any one of thee proteins impairs the repair of DSBs that occur during V(D)J (variable [Diversity] Joining) recombination or after exposure to ionizing radiation. The scid (severe combined immune deficient) defect in mice was recently shown to be caused by a decrease in the level of DNA-PKcs. However, a null mutation has not been generated or observed for any of the genes that code for these proteins in mice, including scid. The gene that codes for Ku80, XRCC5, was mutated in mice by the embryonic stem cell/gene targeting technology. Mice are an ideal system to study DNA repair due to the remarkable similarity to humans and due to the sophisticated genetics. Preliminary results demonstrate the xrcc5 mutation is similar to the scid mutation; both result in immune deficient mice and g-radiation hypersensitive cell lines. However, unlike scid, the xrcc5 mutant mice are severely growth retarded and mutant cell lines proliferate slowly and age rapidly. This proposal will answer: What is the phenotype of xrcc5 mutant cell lines and mice? The specific aims are: 1) Analyze the phenotype of xrcc5 mutant mice. 2) Analyze cell proliferation, aging and radiation sensitivity in xrcc5 mutant cell lines. 3) Characterize the effects of an xrcc5 mutation on lymphocyte development and V(D)J recombination. 4) Analyze the repair of DSBs in mutant cell lines by end-to-end joining and nonhomologous and homologous recombination. Completion of these aims will significantly impact the way we think about the dynamic nature of DNA and may impact therapy for cancer and immune deficiency.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R01
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    393
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    CPA
  • Study Section Name
    Chemical Pathology Study Section
  • Organization Name
    LEXICON PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    THE WOODLANDS
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    77381
  • Organization District
    UNITED STATES